Form D Explorer
Iambic Therapeutics, Inc. · CIK 1997038

Report a data issueCitable research briefCompare issuerPrivate research collection

Iambic Therapeutics, Inc.

CIK 1997038 · Corporation · Inc. DELAWARE · SAN DIEGO, California · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filing history at a glance

The reported offering amount was $49,999,996 in the Apr 8, 2026 filing and $66,500,000 in the Sep 9, 2026 filing. The two records may concern different offerings. All 3 stored filings from Nov 21, 2025 to Sep 9, 2026 are original notices.

Filings
3
Original notices
3
Amendments
0
Activity
Nov 21, 2025
through Sep 9, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldApr 8, 2026 · DSep 9, 2026 · DLater minus earlier
Reported offering amount$49,999,996$66,500,000$16,500,004
Reported amount sold$27,769,668$65,965,000$38,195,332
Reported investor count—16—
Reported minimum investment$0$0$0

Earlier SEC source: 0001997038-26-000001 · Later SEC source: 0001997038-26-000002

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Sep 9, 2026

Reported offering amount
$66,500,000
Reported exemptions
Rule 506(b)
Reported amount sold
$65,965,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (3)